Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 6590609, 17 pages
https://doi.org/10.1155/2017/6590609
Research Article

Cardiac Function Remains Impaired Despite Reversible Cardiac Remodeling after Acute Experimental Viral Myocarditis

1Clinic for General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany
2German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany
3Department of Molecular Pathology, Institute for Pathology, Eberhard-Karls-University Tübingen, Tübingen, Germany
4German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Germany
5Department of Cardiology, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany

Correspondence should be addressed to Diana Lindner; ed.eku@rendnil.d

Received 7 September 2016; Revised 1 December 2016; Accepted 15 December 2016; Published 2 March 2017

Academic Editor: Margarete D. Bagatini

Copyright © 2017 Peter Moritz Becher et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. R. Taqueti, R. N. Mitchell, and A. H. Lichtman, “Protecting the pump: controlling myocardial inflammatory responses,” Annual Review of Physiology, vol. 68, pp. 67–95, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. J. F. Woodruff, “Viral myocarditis. A review,” American Journal of Pathology, vol. 101, no. 2, pp. 425–484, 1980. View at Google Scholar · View at Scopus
  3. A. L. P. Caforio, S. Pankuweit, E. Arbustini et al., “Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases,” European Heart Journal, vol. 34, no. 33, pp. 2636–2648, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Drory, Y. Turetz, Y. Hiss et al., “Sudden unexpected death in persons <40 years of age,” The American Journal of Cardiology, vol. 68, no. 13, pp. 1388–1392, 1991. View at Publisher · View at Google Scholar · View at Scopus
  5. N. R. Rose, “Myocarditis: infection versus autoimmunity,” Journal of Clinical Immunology, vol. 29, no. 6, pp. 730–737, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. M. Feldman and D. McNamara, “Myocarditis,” The New England Journal of Medicine, vol. 343, no. 19, pp. 1388–1398, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Klingel, C. Hohenadl, A. Canu et al., “Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 1, pp. 314–318, 1992. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Klingel, B. M. McManus, and R. Kandolf, “Enterovirus-infected immune cells of spleen and lymph nodes in the murine model of chronic myocarditis: a role in pathogenesis?” European Heart Journal, vol. 16, pp. 42–45, 1995. View at Google Scholar · View at Scopus
  9. K. Klingel, S. Stephan, M. Sauter et al., “Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets,” Journal of Virology, vol. 70, no. 12, pp. 8888–8895, 1996. View at Google Scholar · View at Scopus
  10. A. O. Weinzierl, G. Szalay, H. Wolburg et al., “Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis,” Journal of Virology, vol. 82, no. 16, pp. 8149–8160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Klingel, C. Fabritius, M. Sauter et al., “The activating receptor NKG2D of natural killer cells promotes resistance against enterovirus-mediated inflammatory cardiomyopathy,” Journal of Pathology, vol. 234, no. 2, pp. 164–177, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Fung, H. Luo, Y. Qiu, D. Yang, and B. McManus, “Myocarditis,” Circulation Research, vol. 118, no. 3, pp. 496–514, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Westermann, K. Savvatis, D. Lindner et al., “Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy,” Circulation, vol. 124, no. 19, pp. 2082–2093, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Antoniak, A. P. Owens III, M. Baunacke et al., “PAR-1 contributes to the innate immune response during viral infection,” The Journal of Clinical Investigation, vol. 123, no. 3, pp. 1310–1322, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Weithauser, P. Bobbert, S. Antoniak et al., “Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis,” Journal of the American College of Cardiology, vol. 62, no. 19, pp. 1737–1745, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Lindner, J. Li, K. Savvatis et al., “Cardiac fibroblasts aggravate viral myocarditis: cell specific Coxsackievirus B3 replication,” Mediators of Inflammation, vol. 2014, Article ID 519528, 14 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Jäkel, U. Kuckelkorn, G. Szalay et al., “Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis,” The American Journal of Pathology, vol. 175, no. 2, pp. 510–518, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Jaquenod De Giusti, A. E. Ure, L. Rivadeneyra, M. Schattner, and R. M. Gomez, “Macrophages and galectin 3 play critical roles in CVB3-induced murine acute myocarditis and chronic fibrosis,” Journal of Molecular and Cellular Cardiology, vol. 85, pp. 58–70, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Jenke, L. Holzhauser, M. Löbel et al., “Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses,” Basic Research in Cardiology, vol. 109, no. 3, article 408, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Pinkert, K. Klingel, V. Lindig et al., “Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line,” Journal of Virology, vol. 85, no. 24, pp. 13409–13419, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Klingel, P. Rieger, G. Mall, H.-C. Selinka, M. Huber, and R. Kandolf, “Visualization of enteroviral replication in myocardial tissue by ultrastructural in situ hybridization: identification of target cells and cytopathic effects,” Laboratory Investigation, vol. 78, no. 10, pp. 1227–1237, 1998. View at Google Scholar · View at Scopus
  22. S. Gruhle, M. Sauter, G. Szalay, N. Ettischer, R. Kandolf, and K. Klingel, “The prostacyclin agonist iloprost aggravates fibrosis and enhances viral replication in enteroviral myocarditis by modulation of ERK signaling and increase of iNOS expression,” Basic Research in Cardiology, vol. 107, no. 5, article 287, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Hohenadl, K. Klingel, J. Mertsching, P. H. Hofschneider, and R. Kandolf, “Strand-specific detection of enteroviral RNA in myocardial tissue by in situ hybridization,” Molecular and Cellular Probes, vol. 5, no. 1, pp. 11–20, 1991. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Szalay, M. Sauter, M. Haberland et al., “Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host,” Circulation Research, vol. 104, no. 7, pp. 851–859, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Szalay, S. Meiners, A. Voigt et al., “Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes,” The American Journal of Pathology, vol. 168, no. 5, pp. 1542–1552, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Klingel, J.-J. Schnorr, M. Sauter, G. Szalay, and R. Kandolf, “β2-microglobulin-associated regulation of interferon-γ and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis,” American Journal of Pathology, vol. 162, no. 5, pp. 1709–1720, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Savvatis, S. van Linthout, K. Miteva et al., “Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis,” PLoS ONE, vol. 7, no. 7, Article ID e41047, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Pacher, T. Nagayama, P. Mukhopadhyay, S. Bátkai, and D. A. Kass, “Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats,” Nature Protocols, vol. 3, no. 9, pp. 1422–1434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Lindner, C. Zietsch, J. Tank et al., “Cardiac fibroblasts support cardiac inflammation in heart failure,” Basic Research in Cardiology, vol. 109, no. 5, article 428, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Tank, D. Lindner, X. Wang et al., “Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts,” Journal of Molecular and Cellular Cardiology, vol. 66, pp. 141–156, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method,” Method, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar
  32. D. Westermann, D. Lindner, M. Kasner et al., “Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction,” Circulation: Heart Failure, vol. 4, no. 1, pp. 44–52, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Kawai and S. Akira, “Innate immune recognition of viral infection,” Nature Immunology, vol. 7, no. 2, pp. 131–137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Mercer and U. F. Greber, “Virus interactions with endocytic pathways in macrophages and dendritic cells,” Trends in Microbiology, vol. 21, no. 8, pp. 380–388, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Nahrendorf and F. K. Swirski, “Monocyte and macrophage heterogeneity in the heart,” Circulation Research, vol. 112, no. 12, pp. 1624–1633, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. M. M. Khan, “Role of cytokines,” in Immunopharmacology, pp. 33–59, Springer, New York, Ny, USA, 2008. View at Google Scholar
  37. C. Tschöpe, C.-T. Bock, M. Kasner et al., “High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction,” Circulation, vol. 111, no. 7, pp. 879–886, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Fuse, G. Chan, Y. Liu et al., “Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of coxsackievirus B3-induced myocarditis and influences type I interferon production,” Circulation, vol. 112, no. 15, pp. 2276–2285, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Riad, D. Westermann, C. Zietsch et al., “TRIF is a critical survival factor in viral cardiomyopathy,” The Journal of Immunology, vol. 186, no. 4, pp. 2561–2570, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Jellis, J. Martin, J. Narula, and T. H. Marwick, “Assessment of nonischemic myocardial fibrosis,” Journal of the American College of Cardiology, vol. 56, no. 2, pp. 89–97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. K. T. Weber, R. Pick, J. E. Jalil, J. S. Janicki, and E. P. Carroll, “Patterns of myocardial fibrosis,” Journal of Molecular and Cellular Cardiology, vol. 21, supplement 5, pp. 121–131, 1989. View at Publisher · View at Google Scholar · View at Scopus
  42. S. L. K. Bowers, I. Banerjee, and T. A. Baudino, “The extracellular matrix: at the center of it all,” Journal of Molecular and Cellular Cardiology, vol. 48, no. 3, pp. 474–482, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. F. G. Spinale, M. L. Coker, B. R. Bond, and J. L. Zellner, “Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target,” Cardiovascular Research, vol. 46, no. 2, pp. 225–238, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. F. G. Spinale and M. R. Zile, “Integrating the myocardial matrix into heart failure recognition and management,” Circulation Research, vol. 113, no. 6, pp. 725–738, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. C. D. Buckley, D. Pilling, J. M. Lord, A. N. Akbar, D. Scheel-Toellner, and M. Salmon, “Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation,” Trends in Immunology, vol. 22, no. 4, pp. 199–204, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. R. T. Kendall and C. A. Feghali-Bostwick, “Fibroblasts in fibrosis: novel roles and mediators,” Frontiers in Pharmacology, vol. 5, article no. 123, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Strutz and M. Zeisberg, “Renal fibroblasts and myofibroblasts in chronic kidney disease,” Journal of the American Society of Nephrology, vol. 17, no. 11, pp. 2992–2998, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Sakata, A. L. Chancey, V. G. Divakaran, K. Sekiguchi, N. Sivasubramanian, and D. L. Mann, “Transforming growth factor-β receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor,” Basic Research in Cardiology, vol. 103, no. 1, pp. 60–68, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. P. Teekakirikul, S. Eminaga, O. Toka et al., “Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β,” The Journal of Clinical Investigation, vol. 120, no. 10, pp. 3520–3529, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Li, W. Xu, Q. Guo et al., “Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis,” Circulation Research, vol. 105, no. 4, pp. 353–364, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Marchant, Y. Dou, H. Luo et al., “Bosentan enhances viral load via endothelin-1 receptor type-A-mediated p38 mitogen-activated protein kinase activation while improving cardiac function during coxsackievirus-induced myocarditis,” Circulation Research, vol. 104, no. 6, pp. 813–821, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Kandolf, M. Sauter, C. Aepinus, J.-J. Schnorr, H.-C. Selinka, and K. Klingel, “Mechanisms and consequences of enterovirus persistence in cardiac myocytes and cells of the immune system,” Virus Research, vol. 62, no. 2, pp. 149–158, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. N. L. Rosin, M. J. Sopel, A. Falkenham, T. D. G. Lee, and J.-F. Légaré, “Disruption of collagen homeostasis can reverse established age-related myocardial fibrosis,” The American Journal of Pathology, vol. 185, no. 3, pp. 631–642, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. C. G. Brilla, R. C. Funck, and H. Rupp, “Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease,” Circulation, vol. 102, no. 12, pp. 1388–1393, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. C. G. Brilla, L. Matsubara, and K. T. Weber, “Advanced hypertensive heart disease in spontaneously hypertensive rats: lisinopril-mediated regression of myocardial fibrosis,” Hypertension, vol. 28, no. 2, pp. 269–275, 1996. View at Publisher · View at Google Scholar · View at Scopus
  56. N. Verzijl, J. DeGroot, S. R. Thorpe et al., “Effect of collagen turnover on the accumulation of advanced glycation end products,” The Journal of Biological Chemistry, vol. 275, no. 50, pp. 39027–39031, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Nissen, G. J. Cardinale, and S. Udenfriend, “Increased turnover of arterial collagen in hypertensive rats,” Proceedings of the National Academy of Sciences of the United States of America, vol. 75, no. 1, pp. 451–453, 1978. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Mollova, K. Bersell, S. Walsh et al., “Cardiomyocyte proliferation contributes to heart growth in young humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 4, pp. 1446–1451, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. S. E. Senyo, R. T. Lee, and B. Kühn, “Cardiac regeneration based on mechanisms of cardiomyocyte proliferation and differentiation,” Stem Cell Research, vol. 13, no. 3, pp. 532–541, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Fairweather and N. R. Rose, “Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity,” Methods, vol. 41, no. 1, pp. 118–122, 2007. View at Publisher · View at Google Scholar · View at Scopus